TARGETING THE DNA BINDING DOMAIN OF THE ANDROGEN RECEPTOR: EFFICACY OF PROSTATE CANCER COMPOUND WITH NOVEL MECHANISM OF ACTION

被引：0
|
作者：
Borgmann, Hendrik
Dalal, Kush
Beraldi, Eliana
Cherkasov, Artem
Rennie, Paul
Gleave, Martin
机构：
来源：
JOURNAL OF UROLOGY | 2016年 / 195卷 / 04期
关键词：
D O I：
10.1016/j.juro.2016.02.909
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP62-01
引用
收藏
页码：E812 / E812
页数：1
相关论文
共 50 条
  • [41] Discovery of novel antagonists targeting the DNA binding domain of androgen receptor by integrated docking-based virtual screening and bioassays
    Pang, Jin-ping
    Shen, Chao
    Zhou, Wen-fang
    Wang, Yun-xia
    Shan, Lu-hu
    Chai, Xin
    Shao, Ying
    Hu, Xue-ping
    Zhu, Feng
    Zhu, Dan-yan
    Xiao, Li
    Xu, Lei
    Xu, Xiao-hong
    Li, Dan
    Hou, Ting-jun
    [J]. ACTA PHARMACOLOGICA SINICA, 2022, 43 (01) : 229 - 239
  • [42] DNA licensing as a novel androgen receptor mediated therapeutic target for prostate cancer
    D'Antonio, Jason M.
    Griend, Donald J. Vander
    Isaacs, John T.
    [J]. ENDOCRINE-RELATED CANCER, 2009, 16 (02) : 325 - 332
  • [43] Discovery of novel antagonists targeting the DNA binding domain of androgen receptor by integrated docking-based virtual screening and bioassays
    Jin-ping Pang
    Chao Shen
    Wen-fang Zhou
    Yun-xia Wang
    Lu-hu Shan
    Xin Chai
    Ying Shao
    Xue-ping Hu
    Feng Zhu
    Dan-yan Zhu
    Li Xiao
    Lei Xu
    Xiao-hong Xu
    Dan Li
    Ting-jun Hou
    [J]. Acta Pharmacologica Sinica, 2022, 43 : 229 - 239
  • [44] Androgen receptor degraders and transactivation domain inhibitors targeting castration-resistant prostate cancer
    Elshan, N. G. Ralalage Dayan
    An, Jiabin
    Jung, Michael
    Rettig, Matthew
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [45] Targeting novel co-activators of androgen receptor in castration resistant prostate cancer
    Malik, Rohit
    Khan, Amjad P.
    Prensner, John R.
    Iyer, Matthew K.
    Borkin, Dmitry
    Wang, Xiaoju
    Jiang, Xia
    Subramaniam, Shruthi
    Shi, Yang
    Stender, Rachell
    Wu, Yi-Mi
    Cao, Xuhong
    Grembecka, Jolanta
    Cierpicki, Tomasz
    Chinnaiyan, Arul
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [46] Androgen receptor – an update of mechanisms of action in prostate cancer
    Z. Culig
    A. Hobisch
    G. Bartsch
    H. Klocker
    [J]. Urological Research, 2000, 28 : 211 - 219
  • [47] Androgen receptor - an update of mechanisms of action in prostate cancer
    Culig, Z
    Hobisch, A
    Bartsch, G
    Klocker, H
    [J]. UROLOGICAL RESEARCH, 2000, 28 (04): : 211 - 219
  • [48] ANDROGEN INSENSITIVITY IN THE PRESENCE OF NORMAL ANDROGEN BINDING DUE TO DEFECTS IN THE ANDROGEN RECEPTOR DNA-BINDING DOMAIN
    QUIGLEY, CA
    DEBELLIS, A
    MARSCHKE, KB
    EVANS, BAJ
    SIMENTAL, JA
    WILSON, EM
    FRENCH, FS
    [J]. CLINICAL RESEARCH, 1992, 40 (02): : A338 - A338
  • [49] Computational modeling of novel androgen-receptor binding sites in advanced prostate cancer
    Jackson, Kimberly M.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [50] Sertad1 promotes prostate cancer progression through binding androgen receptor ligand binding domain
    Hu, Bingqing
    Hu, Haidi
    Yin, Mingzhu
    Sun, Zhengrong
    Chen, Xiaoya
    Li, Ying
    Sun, Ziyi
    Liu, Cong
    Li, Ling
    Qiu, Yang
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (03) : 558 - 568
12345